Vitamin E and probucol reduce urinary lipophilic aldehydes and renal enlargement in streptozotocin-induced diabetic rats

Lipids

Volumn 35, Issue 11, 2000, Pages 1225-1237

  Kim, S S ^a   Gallaher, D D ^a   Csallany, A S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENYLHYDRAZINE; ALDEHYDE; ALPHA TOCOPHEROL; CARBONYL DERIVATIVE; HYDRAZONE DERIVATIVE; PROBUCOL; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY HYPERTROPHY; LIPID PEROXIDATION; LIPOPHILICITY; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES;

ANIMALIA;

EID: 0034532423     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-000-0639-2     Document Type: Article

References (57)

1. Lipid peroxidation - A common pathogenetic mechanism?
2. Malondialdehyde (MDA) level in diabetic subjects. Relationship with blood glucose and glycosylated hemoglobin
3. Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus
4. Plasma malondialdehyde in type 1 and type 2 diabetic patients
5. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes
6. Lipid peroxidation and retinopathy in streptozotocin-induced diabetes
7. Role of oxidative stress in development of complications in diabetes
8. Does oxygen free radical increased formation explain long term complications of diabetes mellitus?
9. Free radical generation by early glycation products: A mechanism for accelerated atherogenesis in diabetes
10. Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose
11. Serum antioxidant status in streptozotocin-induced diabetic rat
12. Antioxidants in the serum of children with insulin-dependent diabetes mellitus
13. Reduced vitamin E and increased lipofuscin products in erythrocytes of diabetic rats
14. Diabetes increases excretion of urinary MDA conjugates in rats
15. Second report of the ad hoc committee on standards for nutritional studies
16. Selected method for the determination of ascorbic acid in animal cells, tissues, and fluids
17. Lipid peroxidationin vivo measured by urinary excretion of aldehydes and hydroxy aldehydes
18. Lipophilic aldehydes and related carbonyl compounds in rat and human urine
19. Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients
20. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity
21. The glycosylation of hemoglobin: Relevance to diabetes mellitus
22. Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications?
23. The effect of ascorbate supplementation on oxidative stress in the streptozotocin diabetic rat
24. The natural history and epidemiology of diabetic nephropathy
25. Increased kidney size and glomerular filtration rate in early juvenile diabetes
26. Renal hypertrophy in streptozotocin-diabetic rats
27. The extracellular matrix in diabetic nephropathy
28. Renal hypertrophy in experimental diabetes: Relation to severity of diabetes
29. The effect of dietary fiber type on glycated hemoglobin and renal hypertrophy in the diabetic rat
30. Arrest of glomerulopathy in diabetic dogs by improved glycaemic control
31. Lipid peroxidation, glutathione levels and changes in glutathione-related enzymes activities in streptozotocin-induced diabetic rats
32. Inhibition of glycolytic enzymes by endogenous aldehydes: A possible relation to diabetic neuropathies
33. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
34. Lipid peroxidation. Biopathological significance
35. Biological interactions of α,β-unsaturated aldehydes
36. Diabetes as an atherogenic factor
37. Animal models of diabetes mellitus: Physiology and pathology
38. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients
39. Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator
40. Activation of protein kinase C in glomerular cells in diabetes: Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy
41. Direct measurement of polyol pathway activity in the ocular lens
42. Substrate specificity of human aldose reductase: Identification of 4-hydroxynonenal as an endogenous substrate
43. Physiological substrates of human aldose and aldehyde reductases
44. Glomerular basement membrane thickening in streptozotocin diabetic rats despite treatment with an aldose reductase inhibitor
45. Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptozotocin-diabetic rats
46. Vitamin E normalizes diacylglycerol-protein kinase C activation induced by hyperglycemia in rat vascular tissues
47. Vitamin E suppresses diacylglycerol (DAG) level in thrombin-stimulated endothelial cells through an increase of DAG kinase activity
48. Protein glycation and oxidative stress in diabetes mellitus and ageing
49. Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation
50. Hydroxyalkenal formation induced by advanced glycosylation of low density lipoprotein
51. High glucose reduces specific binding for Dα-tocopherol in cultured aortic endothelial cells
52. Elevated lipid peroxidation and vitamin E-quinone levels in heart ventricles of streptozotocin-treated diabetic rats
53. Decreased susceptibility of liver mitochondria from diabetic rats to oxidative damage and associated increase in α-tocopherol
54. In vivo regulation of lipolysis in humans
55. Probucol as an antioxidant and antiatherogenic drug
56. Antioxidant, probucol, can inhibit the generation of hydrogen peroxide in islet cells induced by macrophages and prevent islet cell destruction in NOD mice
57. Hydroxyalkenals: Cytotoxic products of lipid peroxidation